Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results.
Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%.
GAAP net earnings rose nearly 70% YoY to $2 billion and EPS rose nearly 73% to $1.14. Adjusted EPS grew 22.2% to $1.43.
For FY2022, GAAP EPS is expected to be at least $3.50 and adjusted EPS is expected to be at least $4.90.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
What to expect when J.M. Smucker (SJM) reports Q4 2023 earnings
Shares of the J.M. Smucker Co. (NYSE: SJM) were up over 1% on Friday. The stock has gained 20% over the past one year. The company is slated to report
LULU Earnings: Highlights of Lululemon Athletica’s Q1 2023 financial results
Athletic wear company Lululemon Athletica (NASDAQ: LULU) has reported a double-digit increase in earnings and revenues for the first quarter of 2023. The company also provided positive guidance for the
Five Below (FIVE) Earnings: 1Q23 Key Numbers
Five Below, Inc. (NASDAQ: FIVE) reported net sales of $726.2 million for the first quarter of 2023, up 13.5% from the same period a year ago. Comparable sales increased 2.7%. Net
